The 3q25 rs2305619 Polymorphism Is Associated With Coronary Microvascular Obstruction Following Primary Angioplasty for Acute ST-Segment-Elevation Myocardial Infarction

Circ Cardiovasc Interv. 2019 Dec;12(12):e008228. doi: 10.1161/CIRCINTERVENTIONS.119.008228. Epub 2019 Nov 26.

Authors

Surya Dharma¹, Novi Yanti Sari², Andrew Parlautan², Renan Sukmawan², Shoma Wijaya³, Elok Ekawati³, Anwar Santoso²

Affiliations

¹ Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia (S.D.).
² Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia (N.Y.S, A.P, R.S, A.S).
³ Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia (S.W, E.E).

PMID: 31766867
DOI: 10.1161/CIRCINTERVENTIONS.119.008228

No abstract available

Keywords: adaptive immunity; inflammation; percutaneous coronary intervention; polymorphism, genetic.

Publication types

Letter

MeSH terms

C-Reactive Protein / genetics*
Coronary Circulation*
Coronary Stenosis / diagnostic imaging
Coronary Stenosis / genetics*
Coronary Stenosis / mortality
Coronary Stenosis / physiopathology
Female
Genetic Predisposition to Disease
Humans
Indonesia
Male
Microcirculation
Middle Aged
Percutaneous Coronary Intervention / adverse effects*
Percutaneous Coronary Intervention / mortality
Phenotype
Polymorphism, Single Nucleotide*
Risk Assessment
Risk Factors
ST Elevation Myocardial Infarction / diagnostic imaging
ST Elevation Myocardial Infarction / mortality
ST Elevation Myocardial Infarction / physiopathology
ST Elevation Myocardial Infarction / therapy*
Serum Amyloid P-Component / genetics*
Treatment Outcome

Substances

Serum Amyloid P-Component
PTX3 protein
C-Reactive Protein